Commitments and Contingencies (Details Narrative) - USD ($) $ / shares in Units, $ in Millions			9 Months Ended
	Jun. 10, 2022	Mar. 03, 2022	Sep. 30, 2023	Dec. 31, 2022
Loss Contingencies [Line Items]
Estimated litigation cost			$ 5.9	$ 5.9
Harvard Bioscience Inc. [Member]
Loss Contingencies [Line Items]
Litigation amount received			$ 4.0
Harvard Bioscience Inc. [Member] | Convertible Preferred Stock [Member]
Loss Contingencies [Line Items]
Preferred stock, dividend rate, percentage			8.00%
Harvard Bioscience Inc. [Member] | Series E 8% Convertible Preferred Stock [Member]
Loss Contingencies [Line Items]
Litigation amount received	$ 4.0
Preferred stock, dividend rate, percentage	8.00%
Temporary equity, stock issued	4,000
Temporary equity, issue price per share	$ 1,000
Accrual for contingency matter	$ 3.3
Legal costs on claims against insurance carrier	$ 0.8
Medmarc [Member]
Loss Contingencies [Line Items]
Cash payment received on litigation		$ 0.1